Grafting of 3D Bioprinting to In Vitro Drug Screening: A Review

2020 ◽  
Vol 9 (7) ◽  
pp. 1901773 ◽  
Author(s):  
Jing Nie ◽  
Qing Gao ◽  
Jianzhong Fu ◽  
Yong He
2018 ◽  
Vol 44 ◽  
pp. S110
Author(s):  
T. Agarwal ◽  
T. Maiti ◽  
S. Ghosh

2018 ◽  
Vol 132 ◽  
pp. 235-251 ◽  
Author(s):  
Xuanyi Ma ◽  
Justin Liu ◽  
Wei Zhu ◽  
Min Tang ◽  
Natalie Lawrence ◽  
...  

2020 ◽  
Vol 4 (2) ◽  
pp. 113-125
Author(s):  
Carolina Parra-Cantu ◽  
Wanlu Li ◽  
Alfredo Quiñones-Hinojosa ◽  
Yu Shrike Zhang

The most common and malignant primary brain tumor in adults is glioblastoma (GBM). In vitro 3D brain models are needed to better understand the pathological processes underlying GBM and ultimately develop more efficient antineoplastic agents. Here, we describe the bioprinting methods that have been used to fabricate volumetric GBM models. We explain several factors that should be considered for 3D bioprinting, including bioinks, cells and construct designs, in relation to GBM modeling. Although 3D-bioprinted brain models are still to be improved, they have the potential to become a powerful tool for drug screening.


1984 ◽  
Vol 6 (5) ◽  
pp. 709-716 ◽  
Author(s):  
M. V. Mankar ◽  
R. Jagannathan ◽  
P. R. Mahadevan

2013 ◽  
Vol 65 (11-12) ◽  
pp. 1575-1588 ◽  
Author(s):  
Jonathan H. Tsui ◽  
Woohyuk Lee ◽  
Suzie H. Pun ◽  
Jungkyu Kim ◽  
Deok-Ho Kim

2013 ◽  
Vol 75 (3) ◽  
pp. 282-291 ◽  
Author(s):  
Marcele N. Rocha ◽  
Célia M. Corrêa ◽  
Maria N. Melo ◽  
Stephen M. Beverley ◽  
Olindo Assis Martins-Filho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document